Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Raffles Medical GroupRAFLF 59 3-1 Month Momentum % is -5.28% as of Aug. 21, 2026. GuruFocus rates RAFLF with a GF Score™ of 59/100 and a GF Value™ of $0.82 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 671 Healthcare Providers & Services companies, Raffles Medical Group ranks better than 53.2% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-21), Raffles Medical Group's 3-1 Month Momentum % is -5.28%.
The industry rank for Raffles Medical Group's 3-1 Month Momentum % or its related term are showing as below:
RAFLF's 3-1 Month Momentum % is ranked better than 53.2% of 671
companies
in the Healthcare Providers & Services industry
Industry Median: -1.71
vs RAFLF: -5.28
Raffles Medical Group (OTCPK:RAFLF) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Raffles Medical Group 3-1 Month Momentum % Related Terms
RAFLF vs HCA, THC, DVA: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Raffles Medical Group's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raffles Medical Group 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Raffles Medical Group's 3-1 Month Momentum % falls into.
Raffles Medical Group (OTCPK:RAFLF) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raffles Medical Group (RAFLF) has a 3-1 Month Momentum % of -5.28% as of Aug. 21, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Raffles Medical Group and its competitors. According to the industry distribution chart, Raffles Medical Group ranks #314 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 46.8%.
Is Raffles Medical Group's 3-1 Month Momentum % too high?
Raffles Medical Group's current 3-1 Month Momentum % is -5.28%. Based on the distribution chart, Raffles Medical Group ranks #314 out of 671 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Raffles Medical Group has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #314 out of 671 companies for 3-1 Month Momentum %. This puts Raffles Medical Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Raffles Medical Group and its competitors. Raffles Medical Group's current 3-1 Month Momentum % is -5.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (RAFLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.82, compared to a current price of $0.67 — trading 18.3% below its estimated fair value. The current 3-1 Month Momentum % is -5.28%. Raffles Medical Group's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Raffles Medical Group (RAFLF), the current 3-1 Month Momentum % is -5.28% as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raffles Medical Group (RAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Raffles Medical Group stock appears to be undervalued.
The current stock price of $0.67 is trading 18.3% below its estimated GF Value™ of $0.82.
GuruFocus considers Raffles Medical Group to be Modestly Undervalued.
Key valuation signals for RAFLF:
3-1 Month Momentum %: -5.28%
GF Value™: $0.82 vs. price of $0.67 (18.3% below fair value)
No single metric tells the full story. See the RAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
59GF Score
Get the complete analysis for RAFLF
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RAFLF has been successfully added to your 
